CMS is extending the 2024 merit-based incentive payment system deadline and reopening the extreme and uncontrollable ...

The following is a summary of “Intraosseous versus intravenous vascular access in out-of-hospital cardiac arrest: a ...

Ajai Chari, MD, University of California San Francisco, explores the challenges that accompany integrating chimeric antigen receptor (CAR) T-cell therapies into multiple myeloma treatment.

The FDA has approved Tremfya as the “first and only” interleukin-23 inhibitor that offers both IV and fully subcutaneous ...

Medtronic’s VenaSeal Spectrum postmarket clinical trial program is highlighting the need for further patient-centric ...

Fully discussing conservative management and varicose vein treatment options can empower patients to make the best decision ...

Inside a state prison building, witnesses watched Arizona execute Aaron Gunches without the troubles of the past.

Aaron Gunches is scheduled to be the first person executed by Arizona since 2022. Here's what to know about his planned lethal injection.

Therapy and Vein Access Intravenous Catheters is further classified into Peripheral ... the relationship that exists between a patient/site visitor and his/her physician. Disclaimer: You are now ...

"Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut ...

The Intravenous Therapy and Vein Access Market size was valued at $22.8 billion in 2020, and is estimated to reach $37.5 billion by 2030, growing at a CAGR of 5.1% from 2021 to 2030. Download ...

People can take these orally or through an intravenous (IV) line. Medicare helps pay for chemotherapy deemed medically necessary. How a person receives the treatment and in what setting determines ...